BR MEYER, M LEWIN, DE DRAYER, M … - Annals of internal …, 1984 - Am Coll Physicians Using an original high-pressure liquid chromatographic assay, we measured serum levels of
metoclopramide and defined a concentration-response relationship for metoclopramide control
of cisplatin-induced emesis. Using a metoclopramide regimen of 2 mg/kg body weight ... Cited by 52 - Related articles - All 3 versions
- ►nih.gov [PDF] WD Taylor, DN Bateman - British Journal of Clinical …, 1983 - pubmedcentral.nih.gov Nausea and vomiting are amongst the most trouble- some adverse effects of cytotoxic drug therapy
and in some cases may be so intolerable that patients refuse further treatment. Many anti-emetic
drugs have been used to try to prevent these reactions but most are, at best, only ... Cited by 16 - Related articles - All 3 versions
- ►nih.gov [PDF] DJ Kerr, J Graham, RG Blackie, E … - British Journal of …, 1985 - pubmedcentral.nih.gov Adjepon-Yamoah, K. K., Woolhouse, NM & Pres- cott, L. F. (1985). The effect of chloroquine on
paracetamol kinetics. Br. J. clin. Pharmac. (in press). Bratton, AC & Marshall, EK (1939). A new
coupling component for sulphanilamide deter- mination. J. biol. Chem., 128, 537-550. ... Cited by 9 - Related articles - All 3 versions
- ►nih.gov [PDF] PS Warrington, SG Allan, MA Cornbleet, JS … - British Medical Journal, 1986 - bmj.com Page 1. doi:10.1136/bmj.293.6558.1334 1986;293;1334-1337 Br Med J (Clin Res
Ed) C Leonard PS Warrington, SG Allan, MA Cornbleet, JS MacPherson, JF Smyth
and R induced by cisplatin. infusion of high dose metoclopramide ... Cited by 24 - Related articles - All 6 versions
- ►ascopubs.org [PDF] JE McDermed, JL Cohen, C Joseph, SB … - Journal of Clinical …, 1985 - jco.ascopubs.org H IGH-DOSE intravenous (IV) metoclopra- mide (Reglan, AH Robins, Richmond, Va) has been
shown to be effective in preventing chemotherapy-induced nausea and emesis,'-3 but optimal
results are not always achieved in cispla- tin-treated patients receiving the standard high- ... Cited by 10 - Related articles - All 9 versions
SB Strum, JE McDermed, RW Opfell, LP Riech - JAMA, 1982 - Am Med Assoc An open-label clinical trial was conducted to test the safety and efficacy of intravenous metoclopramide
monohydrochloride in preventing chemotherapy-induced nausea and vomiting. Thirty-eight patients
received a total of 83 assessable courses of chemotherapy with cisplatin alone or in ... Cited by 74 - Related articles - All 2 versions
R Saller, D Hellenbrecht, L Briemann, A Hellstern, … - Clinical Pharmacology & …, 1985 - nature.com Eleven male subjects aged 24 to 58 yr received cisplatin, 90 to 120 mg/m 2 iv, in combination
with other cytostatic drugs such as doxorubicin HC1 and bleomycin. To prevent emesis, two
high-dose metoclopramide regimens were started 2 hr before cytostatic therapy. Regimen ... Cited by 15 - Related articles - All 3 versions
- ►nih.gov [PDF] WB Taylor, SJ Proctor, DN Bateman - British Journal of Clinical …, 1984 - pubmedcentral.nih.gov Page 1. Br. J. clin. Pharmac. (1984), 18, 679-684 Pharmacokinetics and efficacy of
high-dose metoclopramide given by continuous infusion for the control of cytotoxic
drug-induced vomiting WENDY B. TAYLOR', S. J. PROCTOR2 ... Cited by 20 - Related articles - All 3 versions
MS Aapro, DS Alberts - Cancer Chemotherapy and Pharmacology, 1981 - Springer Summary. Severe, debilitating nausea and vomiting are seen in almost 100% of patients treated
with cis-platinum. These side-effects can be so severe and prolonged as to preclude therapy
in a large number of patients. Commonly used antiemetics have had only limited success ... Cited by 61 - Related articles - All 2 versions
